ERAP1 and psoriasis: This was recently demonstrated for the homologous enzyme, ERAP1, in the case of Psoriasis, since reduced ERAP1 activity resulted in the reduced generation of an autoantigenic peptide that sustains cytotoxic T cell activity against melanocytes in patients [16].